The Pharmaceutical Market: Thailand

Date: January 31, 2013
Pages: 102
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P6199D6C698EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Thailand
OVERVIEW OF THE PHARMACEUTICAL MARKET IN THAILAND

The revival of the THB30 healthcare scheme in September 2012 will do little to ease the financial burden the government is facing as a result of the universal healthcare scheme. Nor will it solve existing issues such as the shortage of medical professionals and hospital overcrowding, given that these problems existed when the scheme was first implemented. We highlight that universal healthcare coverage will prove to be financially unsustainable in the long term, due to various factors - including Thailand's ageing population (and therefore increased burden of non-communicable diseases), medical tourism and the creation of the region-wide ASEAN Economic Community 2015 that is leading to the exit of medical professionals from Thailand 's public health sector.

Headline Expenditure Projections

Pharmaceuticals: THB130.95bn (US$4.41bn) in 2011 to THB136.34bn (US$4.18bn) in 2012; +4.1% in local currency terms and -5.1% in US dollar terms. Forecast broadly unchanged from Q4 12.

Healthcare: THB405.84bn (US$13.31bn) in 2011 to THB429.15bn (US$13.16bn) in 2012; +5.7% in local currency terms and -1.1% in US dollar terms. Forecast broadly unchanged from Q4 12.

Medical devices: THB33.88bn (US$1.11bn) in 2011 to THB39.09bn (US$1.20bn) in 2012; +15.4% in local currency terms and 7.9% in US dollar terms. Forecast broadly unchanged from Q4 12.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Thailand Pharmaceutical And Healthcare Industry SWOT
    Thailand Political SWOT
    Thailand Economic SWOT
    Thailand Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Asia Pacific Pharmaceutical And Healthcare Risk/Reward Ratings, Q113
    Rewards
    Risks

THAILAND – MARKET SUMMARY

REGULATORY REGIME

    Recent Regulatory Developments
    Regional Harmonisation
    Intellectual Property Regime
    IP Shortcomings
    Counterfeit Drugs
    Compulsory Licensing
    IP Developments
    Pricing And Reimbursement
    Table: Price Build-Up Of Medicines In Thailand

INDUSTRY TRENDS AND DEVELOPMENTS

    Epidemiology
    Communicable Diseases
    Healthcare System
    Healthcare Insurance
    Table: Various Healthcare Scheme In Thailand
    Medical Tourism
    Research And Development (R&D)
    Biosimilars
    Clinical Trials
    Medical Devices
    Developments In The Medical Devices Sector

INDUSTRY FORECAST SCENARIO

    Overall Market Forecast
    Table: Pharmaceutical Sales Indicators, 2008-2016
    Healthcare Market Forecast
    Table: Healthcare Expenditure Indicators, 2008-2016
    Table: Healthcare Governmental Indicators, 2008-2016
    Table: Healthcare Private Indicators, 2008-2016
  Key Growth Factors – Macroeconomic
    Thailand – Economic Activity
    Prescription Drug Market Forecast
    Table: Prescription Drug Sales Indicators, 2008-2016
    Patented Drug Market Forecast
    Table: Patented Drug Market Indicators, 2008-2016
    Generic Drug Market Forecast
    Table: Generic Drug Sales Indicators, 2008-2016
    OTC Medicine Market Forecast
    Table: OTC Medicine Sales Indicators, 2008-2016
    Table: OTC Medicine Sales Indicators, 2008-2016
    Pharmaceutical Trade Forecast
    Table: Exports and Imports Indicators, 2008-2016
  Medical Device Market Forecast
    Table: Medical Devices Sales Indicators, 2008-2016
    Other Healthcare Data
    Key Risks To BMI’s Forecasts

COMPETITIVE LANDSCAPE

    Pharmaceutical Industry
    Domestic Pharmaceutical Industry
    Table: Pharmaceutical Manufacturers Of Modern Drugs, 2007-2012
    Table: Pharmaceutical Production At Wholesale Prices, 1983-2010
    Foreign Pharmaceutical Industry
    Table: PReMA Members, 2012
    Recent Pharmaceutical Industry Developments
    Pharmaceutical Wholesale
    Pharmaceutical Retail
    Table: Pharmacies By Region, 2000-09

COMPANY PROFILES

  Domestic Companies
    Siam Pharmaceutical
    Government Pharmaceutical Organisation (GPO)
    Biolab
    Thai Meiji Pharmaceutical Company
    Berlin Pharmaceutical Industry
  Multinational Companies
    Pfizer
    Sanofi
    GlaxoSmithKline (GSK)
    Merck & Co
    Novartis

DEMOGRAPHIC DATA

    THAILAND – Population By Age Group
    THAILAND – Population By Age Group
    THAILAND – Key Population Ratios
    THAILAND – Rural And Urban Population

GLOSSARY

BMI METHODOLOGY

    How We Generate Our Pharmaceutical Industry Forecasts

PHARMACEUTICALS BUSINESS ENVIRONMENT RATINGS

    Risk/Reward Ratings Methodology
    Ratings Overview
    Table: Pharmaceutical Business Environment Indicators
    Weighting
    Table: Weighting Of Components
    Sources
Skip to top


The Pharmaceutical Market: Germany US$ 1,295.00 Jan, 2013 · 112 pages
The Pharmaceutical Market: Hungary US$ 1,295.00 Jan, 2013 · 95 pages
The Pharmaceutical Market: India US$ 1,295.00 Jan, 2013 · 117 pages

Ask Your Question

The Pharmaceutical Market: Thailand
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: